Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

Employee Benefits Update - July 1, 2004

Related Content

ERISA Litigation Update

A Step Towards Guidance Instead of Regulation by Litigation in the ESOP Space

ERISA Litigation Update

Part III: What Primary Mitigation Strategies Exist for Companies with Double-Vest RSUs That May Be Expiring?

Part II: Why Do Private Companies Shift From Stock Options to Double-Vest RSUs?

Part I: What are “Double-Vest” RSUs and Why Are They Making Headlines?

Deadline Approaching for Reporting 2022 ISO Exercises and ESPP Transfers

ERISA Litigation Update

Pathology Watch to be Acquired by Sonic Healthcare

TQ Ventures and Menlo Ventures Co-Lead Cleanlab’s $25 Million Series A Investment

Orchard Therapeutics To Be Acquired By Kyowa Kirin For $387 Million and Contingent Value Rights

Parent Companies of Cape Cod 5 and Fidelity Bank Agree To Combine

iRobot Enters Financing Facility and Modifies Amazon Merger Price

Versanis Bio To Be Acquired By Eli Lilly In A Transaction Valued Up To $1.925 Billion

Bobbie Acquires Nature’s One

Tata Communications To Acquire Kaleyra For $100 Million

ERISA & Executive Compensation